Drug Shortage Report for APIDRA

Last updated on 2020-01-28 History
Report ID 99690
Drug Identification Number 02279460
Brand name APIDRA
Common or Proper name Apidra
Market Status MARKETED
Active Ingredient(s) INSULIN GLULISINE
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 1
ATC code A10AB
Reason for shortage Other (Please describe in comments)
Anticipated start date 2020-01-15
Actual start date
Estimated end date 2020-02-10
Actual end date 2020-01-27
Shortage status Resolved
Updated date 2020-01-28
Company comments Production delay - The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-11-26 English Compare
v2 2019-11-26 French Compare
v3 2020-01-16 English Compare
v4 2020-01-27 English Compare
v5 2020-01-27 French Compare
v6 2020-01-27 English Compare
v7 2020-01-27 French Compare
v8 2020-01-28 English Compare

Showing 1 to 8 of 8